Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis

Acta Derm Venereol. 2009 Nov;89(6):653-4. doi: 10.2340/00015555-0728.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Biopsy
  • Etanercept
  • Humans
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin G / adverse effects*
  • Lymphoma, T-Cell, Cutaneous / chemically induced*
  • Lymphoma, T-Cell, Cutaneous / pathology
  • Male
  • Receptors, Tumor Necrosis Factor / administration & dosage
  • Skin / pathology
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / pathology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept